Business Wire

GA Telesis Announces Launch of $500 Million GAIN 2 Fund


GA Telesis, LLC (“GA Telesis”) and Wafra Capital Partners Inc. (“WCP Inc.”) jointly announced today that GA Telesis has raised a new $500 million investment vehicle from institutional and private clients advised by WCP Inc. to establish a second aviation investment vehicle focused on aircraft and engine investment opportunities. This capital raise constitutes the second round of funding from WCP Inc.

The vehicle will be named GA Telesis Aviation Investments 2 LLC (“GAIN 2”) and will be managed by GA Telesis Capital Management, LLC, a wholly owned subsidiary of GA Telesis. Together with this capital raise, GA Telesis’ own capital, and existing credit facilities, GA Telesis Aviation Investments LLC’s capacity for investments is up to $2 billion.

In 2014, GA Telesis and WCP Inc. launched GAIN 1. The vehicle’s realized performance to date has exceeded expectations on a broad range of investments in commercial aircraft and engine leases. Almost all assets in GAIN 1 have been harvested.

GAIN 2 will seek to make investments in commercial aircraft, engines, airport infrastructure equipment and new generation component inventories, for long-term or short-term lease and financing. GAIN 2 has the broad flexibility to make investments with a variety of durations over a wide range of asset types and across the capital structure. GA Telesis currently owns and manages a fleet of 30 aircraft and 60 engines and has disassembled an unprecedented 300 aircraft and 700 engines since 2002.

“We achieved a significant realized return for WCP Inc. in the original GAIN vehicle,” commented GA Telesis CEO, Abdol Moabery. “We are pleased to be WCP’s ongoing strategic aviation investment partner with the launch of GAIN 2 and this is yet another affirmation of GA Telesis’ ability to raise capital and deliver on an impressive record of identifying and managing aviation investments.”

“Partnering with GA Telesis in GAIN 1 delivered excellent returns. Naturally, we are thrilled to invest in GAIN 2 alongside this successful management team,” said Michael Gontar, Chief Investment Officer of WCP Inc.

About GA Telesis

GA Telesis is the global provider of integrated aviation solutions serving the aviation and aerospace industries. The Company helps its customers achieve higher levels of performance by creating custom-tailored, multi-faceted solutions integrating its financial asset structuring expertise with component supply chain solutions, jet engine, aircraft systems and aerostructures MRO services. GA Telesis serves over 2,000 customers on six continents supporting all Airbus, Boeing, Bombardier and Embraer aircraft as well as CFM International, General Electric, International Aero Engines, Pratt & Whitney, and Rolls-Royce jet engines.

About WCP Inc.

WCP Inc., a New York-based SEC-registered investment adviser, provides investment advisory services to its clients and focuses on structuring and advising investment vehicles, on a principally Shariah-compliant basis, in the asset-based, structured finance and real estate arenas. WCP Inc., originally the Structure Finance division of Wafra Investment Advisory Group, Inc., became a separate SEC registered adviser in 2011 and is majority beneficially owned by the Public Institution for Social Security of Kuwait, an autonomous agency controlled by Kuwait. WCP Inc.’s senior leadership is comprised of the former employees Structured Finance and Business & Product Development Divisions.

Contact information

GA Telesis, LLC
Cathy Moabery, 954-676-3111

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 21:28Tiedote

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 19:05Tiedote

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 15:52Tiedote

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 15:50Tiedote

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 15:46Tiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 15:00Tiedote

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme